Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium
Birgitta Sander, Daphne de Jong, Andreas Rosenwald, et al.
Haematologica (2014) Vol. 99, Iss. 4, pp. 715-725
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Dreyling, Elı́as Campo, Olivier Hermine, et al.
Annals of Oncology (2017) Vol. 28, pp. iv62-iv71
Open Access | Times Cited: 693
The tumour microenvironment in B cell lymphomas
David W. Scott, Randy D. Gascoyne
Nature reviews. Cancer (2014) Vol. 14, Iss. 8, pp. 517-534
Closed Access | Times Cited: 478
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Dreyling, Michele Ghielmini, Simon Rule, et al.
Annals of Oncology (2020) Vol. 32, Iss. 3, pp. 298-308
Open Access | Times Cited: 205
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
Sarah Huet, Bruno Tesson, Jean‐Philippe Jais, et al.
The Lancet Oncology (2018) Vol. 19, Iss. 4, pp. 549-561
Open Access | Times Cited: 203
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Dreyling, Michele Ghielmini, Simon Rule, et al.
Annals of Oncology (2016) Vol. 27, pp. v83-v90
Open Access | Times Cited: 194
Regulatory B cells in anti-tumor immunity
Yu Zhang, Nicolas Gallastegui, Joseph D. Rosenblatt
International Immunology (2015) Vol. 27, Iss. 10, pp. 521-530
Open Access | Times Cited: 119
The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association
Robert Kridel, Luc Xerri, Bénédicte Gelas‐Dore, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 15, pp. 3428-3435
Open Access | Times Cited: 112
The European Hematology Association Roadmap for European Hematology Research: a consensus document
Andreas Engert, C. Balduini, Anneke Brand, et al.
Haematologica (2016) Vol. 101, Iss. 2, pp. 115-208
Open Access | Times Cited: 74
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Dreyling, Michele Ghielmini, Robert Marcus, et al.
Annals of Oncology (2014) Vol. 25, pp. iii76-iii82
Open Access | Times Cited: 71
Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP
Rita Coutinho, Andrew Clear, Emanuele Mazzola, et al.
Haematologica (2014) Vol. 100, Iss. 3, pp. 363-369
Open Access | Times Cited: 57
Can histologic transformation of follicular lymphoma be predicted and prevented?
Robert Kridel, Laurie H. Sehn, Randy D. Gascoyne
Blood (2017) Vol. 130, Iss. 3, pp. 258-266
Open Access | Times Cited: 54
Confiabilidad, precisión o reproducibilidad de las mediciones. Métodos de valoración, utilidad y aplicaciones en la práctica clínica
Carlos Manterola, Luís Grande, Támara Otzen, et al.
Revista chilena de infectología (2018) Vol. 35, Iss. 6, pp. 680-688
Open Access | Times Cited: 53
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
G. Tjitske Los-de Vries, Wendy B.C. Stevens, Erik van Dijk, et al.
Blood Advances (2022) Vol. 6, Iss. 18, pp. 5482-5493
Open Access | Times Cited: 25
Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis
Takumi Sugimoto, Takashi Watanabe
Journal of Clinical and Experimental Hematopathology (2016) Vol. 56, Iss. 1, pp. 1-19
Open Access | Times Cited: 46
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium
Wendy B.C. Stevens, Matías Mendeville, Robert Redd, et al.
Haematologica (2017) Vol. 102, Iss. 8, pp. 1413-1423
Open Access | Times Cited: 45
Microenvironment Cell Contribution to Lymphoma Immunity
Deepika Kumar, Mina L. Xu
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 45
T-Cell Levels Are Prognostic in Mantle Cell Lymphoma
Lina Nygren, Agata M. Wasik, Stefanie Baumgartner-Wennerholm, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 23, pp. 6096-6104
Open Access | Times Cited: 43
New Paradigms in Mantle Cell Lymphoma: Is It Time to Risk-Stratify Treatment Based on the Proliferative Signature?
Martin Dreyling, Simone Ferrero, Niklas Vogt, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 20, pp. 5194-5206
Closed Access | Times Cited: 31
Robust and accurate quantification of biomarkers of immune cells in lung cancer micro-environment using deep convolutional neural networks
L Aprupe, Geert Litjens, Titus J. Brinker, et al.
PeerJ (2019) Vol. 7, pp. e6335-e6335
Open Access | Times Cited: 28
Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients
Luc Xerri, Sarah Huet, Jeffrey M. Venstrom, et al.
Human Pathology (2017) Vol. 64, pp. 128-136
Closed Access | Times Cited: 28
Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis
Luc Xerri, Emmanuel Bachy, Bettina Fabiani, et al.
Human Pathology (2014) Vol. 45, Iss. 10, pp. 2085-2093
Closed Access | Times Cited: 25
The MCL35 gene expression proliferation assay predicts high‐risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy
Harald Holte, Klaus Beiske, Merrill Boyle, et al.
British Journal of Haematology (2018) Vol. 183, Iss. 2, pp. 225-234
Open Access | Times Cited: 25
Acne image analysis: lesion localization and classification
Fazly Salleh Abas, Benjamin H. Kaffenberger, Joseph Bikowski, et al.
Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE (2016) Vol. 9785, pp. 97850B-97850B
Closed Access | Times Cited: 22
Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy
Thomas Menter, Alexandar Tzankov, Emanuele Zucca, et al.
British Journal of Haematology (2020) Vol. 189, Iss. 4, pp. 707-717
Open Access | Times Cited: 18
High inter‐follicular spatial co‐localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma
Yeman Brhane Hagos, Ayse U. Akarca, Alan Ramsay, et al.
Hematological Oncology (2022) Vol. 40, Iss. 4, pp. 541-553
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top